Global health impact: extending access to essential medicines

Nicole Hassoun here makes a philosophical argument for health, and access to essential medicines, as essential human rights, and she proposes the Global Health Impact system as a way to ensure those rights. She reports how life-saving medicines are inaccessible and costly for the global poor, and that rather than focusing on treatments for critical, deadly global health problems, pharmaceutical companies instead invest in more profitable drugs. To address this problem, Hassoun's proposal will rate pharmaceutical companies based on their medicines' impact on the improvement of global health, and will reward highly-rated medicines with a Global Health Impact label

Human rights and access to essential medicines -- The human right to health and the virtue of creative resolve -- Promoting global health : the case for a Global Health Impact labelling and licensing -- Individual responsibility for promoting global health : the case for a new kind of socially conscious consumption -- Consumption and social change : the case of Global Health Impact certification -- Beyond experimental political philosophy : evaluating Global Health Impact certification -- Conclusion: Beyond Global Health Impact labelling, licensing, and investment : advancing public health.